Proposed rituximab biosimilar BCD‐020 versus reference rituximab for treatment of patients with indolent non‐Hodgkin lymphomas: An international multicenter randomized trial

2020 ◽  
Vol 38 (1) ◽  
pp. 67-73 ◽  
Author(s):  
Irina V. Poddubnaya ◽  
Sergey M. Alekseev ◽  
Kamil D. Kaplanov ◽  
Les M. Lukavetskyy ◽  
Grigoriy B. Rekhtman ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document